GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipca Laboratories Ltd (BOM:524494) » Definitions » Cyclically Adjusted PB Ratio

Ipca Laboratories (BOM:524494) Cyclically Adjusted PB Ratio : 7.85 (As of May. 28, 2024)


View and export this data going back to 1994. Start your Free Trial

What is Ipca Laboratories Cyclically Adjusted PB Ratio?

As of today (2024-05-28), Ipca Laboratories's current share price is ₹1295.85. Ipca Laboratories's Cyclically Adjusted Book per Share for the fiscal year that ended in Mar23 was ₹165.00. Ipca Laboratories's Cyclically Adjusted PB Ratio for today is 7.85.

The historical rank and industry rank for Ipca Laboratories's Cyclically Adjusted PB Ratio or its related term are showing as below:

BOM:524494' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 4.09   Med: 6.76   Max: 8.91
Current: 7.87

During the past 13 years, Ipca Laboratories's highest Cyclically Adjusted PB Ratio was 8.91. The lowest was 4.09. And the median was 6.76.

BOM:524494's Cyclically Adjusted PB Ratio is ranked worse than
90.76% of 693 companies
in the Drug Manufacturers industry
Industry Median: 1.86 vs BOM:524494: 7.87

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Ipca Laboratories's adjusted book value per share data of for the fiscal year that ended in Mar23 was ₹230.269. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₹165.00 for the trailing ten years ended in Mar23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Ipca Laboratories Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Ipca Laboratories's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ipca Laboratories Cyclically Adjusted PB Ratio Chart

Ipca Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.17 6.43 7.61 7.36 4.91

Ipca Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 4.91 - - -

Competitive Comparison of Ipca Laboratories's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Ipca Laboratories's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ipca Laboratories's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ipca Laboratories's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Ipca Laboratories's Cyclically Adjusted PB Ratio falls into.



Ipca Laboratories Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Ipca Laboratories's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=1295.85/165
=7.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ipca Laboratories's Cyclically Adjusted Book per Share for the fiscal year that ended in Mar23 is calculated as:

For example, Ipca Laboratories's adjusted Book Value per Share data for the fiscal year that ended in Mar23 was:

Adj_Book=Book Value per Share/CPI of Mar23 (Change)*Current CPI (Mar23)
=230.269/146.8646*146.8646
=230.269

Current CPI (Mar23) = 146.8646.

Ipca Laboratories Annual Data

Book Value per Share CPI Adj_Book
201403 77.642 91.425 124.724
201503 87.027 97.163 131.544
201603 89.509 102.518 128.228
201703 97.277 105.196 135.809
201803 106.521 109.786 142.496
201903 123.559 118.202 153.520
202003 143.547 124.705 169.055
202103 185.316 131.771 206.544
202203 215.362 138.822 227.839
202303 230.269 146.865 230.269

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Ipca Laboratories  (BOM:524494) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Ipca Laboratories Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Ipca Laboratories's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Ipca Laboratories (BOM:524494) Business Description

Traded in Other Exchanges
Address
125, Kandivli Industrial Estate, Kandivli (West), Mumbai, MH, IND, 400067
Ipca Laboratories Ltd is a specialty and generic drug manufacturing company. The company's principal activity is Development, Manufacturing and Marketing of Pharmaceuticals Products. The company operates multiple subsidiaries with revenue generation split roughly between India and the rest of the world. Ipca's products are exported to more than 100 countries across the globe. Ipca has only one reportable primary business segment, pharmaceuticals.

Ipca Laboratories (BOM:524494) Headlines

No Headlines